{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:29:56Z","timestamp":1776752996296,"version":"3.51.2"},"update-to":[{"DOI":"10.1002\/14651858.cd003545","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2004,1,26]],"date-time":"2004-01-26T00:00:00Z","timestamp":1075075200000}}],"reference-count":163,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003545.pub2","type":"journal-article","created":{"date-parts":[[2004,1,29]],"date-time":"2004-01-29T18:02:36Z","timestamp":1075399356000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Trifluoperazine for schizophrenia"],"prefix":"10.1002","author":[{"given":"Luciana de Oliveira","family":"Marques","sequence":"first","affiliation":[{"name":"Mestrado de Sa\u00fade e Comportamento-Universidade Cat\u00f3lica de Pelotas; Psychiatry; Gon\u00e7alves Chaves 962 sala 302 Pelotas Rio Grande do Sul Brazil 96015-560"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Soares","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo; Brazilian Cochrane Centre; Rua Pedro de Toledo 598 S\u00e3o Paulo SP Brazil 04039-001"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Silva de Lima","sequence":"additional","affiliation":[{"name":"Eli Lilly & Co; Medical; Lilly House Priestley Road Basingstoke Hampshire UK RG24 9NL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,1,26]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/j.1552-4604.1973.tb00068.x","article-title":"A comparison of fluspirilene and trifluoperazine in the treatment of acute schizophrenic psychosis","volume":"13","author":"Bankier","year":"1973","journal-title":"The Journal of Clinical Pharmacology and New Drugs"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0002|cit2","first-page":"3","article-title":"Centbutindole vs trifluoperazine: a double-blind controlled clinical study in acute schizophrenia","volume":"35","author":"Doongaji","year":"1989","journal-title":"Journal of Postgraduate Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003545.pub2-BIB0003|cit3","first-page":"236","article-title":"Haloperidol in controlling the symptoms of acute psychoses. Part II: A double-blind evaluation of haloperidol and trifluoperazine","volume":"8","author":"Goldstein","year":"1966","journal-title":"Current Therapeutic Research"},{"issue":"5","key":"10.1002\/14651858.CD003545.pub2-BIB0004|cit4","first-page":"25","article-title":"Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients","volume":"3","author":"Itil","year":"1971","journal-title":"Behavioral Neuropsychiatry"},{"issue":"9","key":"10.1002\/14651858.CD003545.pub2-BIB0005|cit5","first-page":"6","article-title":"Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.","volume":"3","author":"Itil","year":"1971","journal-title":"Behavioral Neuropsychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0006|cit6","first-page":"22","article-title":"Pimozide: a comparative study in the treatment of chronic schizophrenic patients","volume":"6","author":"Pinard","year":"1972","journal-title":"International Journal of Clinical Pharmacology Therapy and Toxicology"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/009127007101100311","article-title":"A Double-blind comparison of molindone and trifluoperazine in the treatment of acute schizophrenia","volume":"11","author":"Simpson","year":"1971","journal-title":"The Journal of Clinical Pharmacology and New Drugs"},{"issue":"12","key":"10.1002\/14651858.CD003545.pub2-BIB0008|cit8","first-page":"821","article-title":"Differential drug effects of the two phenothiazines. (A controlled comparison of thioridazine and trifluoperazine in chronic schizophrenics)","volume":"31","author":"Vestre","year":"1970","journal-title":"Diseases of the Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0009|cit9","first-page":"15","article-title":"A standard (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients","volume":"13","author":"Amin","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD003545.pub2-BIB0010|cit10","first-page":"72","article-title":"The treatment of chronic schizophrenia. Preliminary results of a controlled comparison of pimozide (Orap) with trifluoperazine","volume":"8","author":"Andersen","year":"1971","journal-title":"Clinical Trials Journal"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0447.1974.tb08043.x","article-title":"A controlled trial of pimozide and trifluoperazine in chronic schizophrenic syndromes","volume":"249 supplement","author":"Andersen","year":"1974","journal-title":"Acta Psychiatr Scand Acta Psychiatr Scand"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0012|cit12","first-page":"13","article-title":"A double-blind comparison of the acridane derivative, clomacran phosphate and trifluoperazine in schizophrenia","volume":"1","author":"Angus","year":"1969","journal-title":"Behavioral Neuropsychiatry"},{"issue":"6","key":"10.1002\/14651858.CD003545.pub2-BIB0013|cit13","first-page":"886","article-title":"A double-blind controlled trial of loxapine and trifluoperazine in adolescent schizophrenia","volume":"27","author":"Bagadia","year":"1980","journal-title":"Current Therapeutic Research Clinical & Experimental"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0014|cit14","first-page":"56","article-title":"A comparative study of fluphenazine enanthate and trifluoperazine in chronic schizophrenic patients","volume":"29","author":"Bankier","year":"1968","journal-title":"Diseases of The Nervous System"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0015|cit15","first-page":"23","article-title":"A comparison of SKF-7261 and trifluoperazine (Stelazine) in the treatment of chronic schizophrenic patients","volume":"5","author":"Bishop","year":"1963","journal-title":"Journal of Neuropsychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0016|cit16","first-page":"674","article-title":"A controlled evaluation of butaperazine in chronic schizophrenic patients","volume":"25","author":"Bishop","year":"1964","journal-title":"Diseases of the Nervous System"},{"issue":"11","key":"10.1002\/14651858.CD003545.pub2-BIB0017|cit17","first-page":"509","article-title":"Thiothixene versus trifluoperazine in newly-admitted schizophrenic patients","volume":"8","author":"Bishop","year":"1966","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"6","key":"10.1002\/14651858.CD003545.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/j.1552-4604.1967.tb00077.x","article-title":"A controlled study of SKF 14336 in acute schizophrenia","volume":"7","author":"Bishop","year":"1967","journal-title":"Journal of Clinical Pharmacology and the Journal of New Drugs"},{"issue":"9","key":"10.1002\/14651858.CD003545.pub2-BIB0019|cit19","first-page":"594","article-title":"Loxapine: a controlled evaluation in chronic schizophrenic patients","volume":"12","author":"Bishop","year":"1970","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"6","key":"10.1002\/14651858.CD003545.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/j.1552-4604.1968.tb00116.x","article-title":"Comparative effects of intramuscular thiothixene and trifluoperazine in psychotic patients","volume":"8","author":"Brauzer","year":"1968","journal-title":"The Journal of Clinical Pharmacology and New Drugs"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0021|cit21","first-page":"152","article-title":"A clinical comparison of molindone hydrochloride with trifluoperazine in psychotic outpatients","volume":"13","author":"Brauzer","year":"1971","journal-title":"Current Therapeutic Research"},{"issue":"9","key":"10.1002\/14651858.CD003545.pub2-BIB0022|cit22","first-page":"1005","article-title":"A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients","volume":"16","author":"Claghorn","year":"1974","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD003545.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/j.1552-4604.1975.tb01450.x","article-title":"Loxapine in newly admitted chronic schizophrenic patients","volume":"15","author":"Clark","year":"1975","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/070674376200700403","article-title":"Chlorpromazine, trifluoperazine and placebo with long-term mental hospital patients","volume":"7","author":"Coons","year":"1962","journal-title":"Canadian Psychiatric Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD003545.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0033-3182(72)71445-0","article-title":"Double blind comparison of thiothixene and trifluoperazine in acute schizophrenia","volume":"13","author":"Denber","year":"1972","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1002\/14651858.CD003545.pub2-BIB0026|cit26","first-page":"582-3, 586-7","article-title":"A twelve month comparison of penfluridol and trifluoperazine in chronic schizophrenic outpatients","volume":"39","author":"Donlon","year":"1978","journal-title":"Journal of Clinical Psychiatry Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1192\/bjp.137.6.522","article-title":"Controlled trial of sulpiride in chronic schizophrenic patients","volume":"137","author":"Edwards","year":"1980","journal-title":"British Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD003545.pub2-BIB0028|cit28","first-page":"537","article-title":"A double-blind study of SKF 14336 vs. trifluoperazine in schizophrenic patients","volume":"10","author":"Freeman","year":"1968","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"9","key":"10.1002\/14651858.CD003545.pub2-BIB0029|cit29","first-page":"441","article-title":"Molindone: a controlled evaluation in chronic schizophrenic patients","volume":"10","author":"Gallant","year":"1968","journal-title":"Current Therapeutic Research Clinical & Experimental"},{"issue":"11","key":"10.1002\/14651858.CD003545.pub2-BIB0030|cit30","first-page":"561","article-title":"Thiothixene: a controlled evaluation of the intramuscular antipsychotic preparation","volume":"10","author":"Gallant","year":"1968","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"4","key":"10.1002\/14651858.CD003545.pub2-BIB0031|cit31","first-page":"215","article-title":"GP-45795: a controlled evaluation in chronic schizophrenic patients","volume":"14","author":"Gallant","year":"1972","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"7","key":"10.1002\/14651858.CD003545.pub2-BIB0032|cit32","first-page":"696","article-title":"A double-blind comparison of once-a-day pimozide, trifluoperazine and placebo in the maintenance care of chronic schizophrenic outpatients","volume":"16","author":"Gross","year":"1974","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00005053-196205000-00008","article-title":"Efficacy of trifluoperazine on withdrawal in chronic schizophrenia","volume":"134","author":"Gwynne","year":"1962","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"6","key":"10.1002\/14651858.CD003545.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/030006057600400611","article-title":"A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients","volume":"4","author":"Kiloh","year":"1976","journal-title":"Journal of International Medical Research"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0035|cit35","first-page":"432","article-title":"Loxapine in adolescent schizophrenia- a comparative study with trifluoperazine","volume":"28","author":"Malik","year":"1980","journal-title":"Current Therapeutic Research Clinical & Experimental"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/070674376400900404","article-title":"Withdrawal of long term phenothiazines from chronically hospitalized psychiatric patients","volume":"60","author":"Marjerrison","year":"1964","journal-title":"Canadian Psychiatric Association Journal"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/070674376601100106","article-title":"A comparison of two butirophenones with trifluoperazine","volume":"11","author":"Marjerrison","year":"1966","journal-title":"Canadian Psychiatric Association Journal"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0038|cit38","first-page":"17","article-title":"A controlled clinical trial of trifluperidol on a group of chronic schizophrenic patients","volume":"14","author":"Menon","year":"1972","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"11","key":"10.1002\/14651858.CD003545.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.5694\/j.1326-5377.1969.tb107260.x","article-title":"A comparison of an acridan derivative (Smith Kline and French 14336) and trifluoperazine in the treatment of chronic schizophrenia","volume":"2","author":"Needham","year":"1969","journal-title":"The Medical Journal of Australia"},{"issue":"2","key":"10.1002\/14651858.CD003545.pub2-BIB0040|cit40","first-page":"75","article-title":"Management of hostile, suspicious patients: trifluoperazine versus haloperidol","volume":"35","author":"O'Brien","year":"1974","journal-title":"Diseases of the Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0041|cit41","first-page":"207","article-title":"Comparative study of clotiapine and trifluoperazine in acute paranoid schizophrenia","volume":"20","author":"Perales","year":"1974","journal-title":"Acta Psiquiatrica y Psicologica de America Latina"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1176\/ajp.126.3.305","article-title":"High dose trifluoperazine therapy in chronic schizophrenia","volume":"126","author":"Prien","year":"1969","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD003545.pub2-BIB0043|cit43","first-page":"438","article-title":"A comparative study of molindone and trifluoperazine","volume":"12","author":"Ramsay","year":"1970","journal-title":"Current Therapeutic Research"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0044|cit44","first-page":"46","article-title":"Clinical evaluation of a new psychotropic drug-Molindone","volume":"3","author":"Ramsay","year":"1970","journal-title":"International Journal of Clinical Pharmacology, Therapy and Toxicology"},{"issue":"4","key":"10.1002\/14651858.CD003545.pub2-BIB0045|cit45","first-page":"265","article-title":"Acute paranoid schizophrenia (treatment with chlorpromazine, trifluoperazine and placebo)","volume":"27","author":"Reardon","year":"1966","journal-title":"Diseases of the Nervous System"},{"issue":"4","key":"10.1002\/14651858.CD003545.pub2-BIB0046|cit46","first-page":"414","article-title":"A double-blind comparison of the onset of activity of haloperidol and trifluoperazine","volume":"8","author":"Rubin","year":"1971","journal-title":"Alabama Journal of Mental Science"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0047|cit47","first-page":"151","article-title":"A comparison of thioridazine, trifluoperazine, chlorpromazine and placebo: A double-blind controlled study on the treatment of chronic hospitalized schizophrenic patients","volume":"22","author":"Schiele","year":"1961","journal-title":"Journal of Clinical and Experimental Psychopathology"},{"issue":"5","key":"10.1002\/14651858.CD003545.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0010-440X(69)90062-5","article-title":"A double-blind comparison of trifluperidol and trifluoperazine in acute schizophrenic patients","volume":"10","author":"Schiele","year":"1969","journal-title":"Comprehensive Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003545.pub2-BIB0049|cit49","first-page":"320","article-title":"A double-blind comparative trial of loxapine and trifluoperazine in chronic schizophrenic patients","volume":"25","author":"Seth","year":"1979","journal-title":"Current Therapeutic Research"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/j.1552-4604.1976.tb01492.x","article-title":"A double-blind comparison of loxapine succinate and trifluoperazine in newly admitted schizophrenic patients","volume":"16","author":"Simpson","year":"1976","journal-title":"Journal of Clinical Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD003545.pub2-BIB0051|cit51","first-page":"23","article-title":"Haloperidol-new addition to the drug treatment of schizophrenia","volume":"1","author":"Stewart","year":"1969","journal-title":"Behavioral Neuropsychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003545.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/j.1552-4604.1965.tb00253.x","article-title":"Trifluperidol and trifluoperazine in acute schizophrenic patients","volume":"5","author":"Sugerman","year":"1965","journal-title":"Journal of New Drugs"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0053|cit53","first-page":"17","article-title":"A standard (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II","volume":"13","author":"Vergara","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1192\/bjp.151.2.152","article-title":"The efficacy of electroconvulsive therapy in the treatment of schizophrenia. A comparative study","volume":"151","author":"Abraham","year":"1987","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1176\/ajp.115.9.812","article-title":"Trifluoperazine in the treatment of chronic schizophrenics","volume":"115","author":"Barsa","year":"1959","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/archpsyc.1969.01740210028004","article-title":"Effects of selected phenothiazines on REM sleep in schizophrenics","volume":"21","author":"Brannen","year":"1969","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1176\/ajp.117.11.1030","article-title":"A study combined therapy with stelazine and parnate(SKF 385) in chronic anergic schizophrenics","volume":"117","author":"Buffaloe","year":"1961","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003545.pub2-BIB0058|cit58","first-page":"251","article-title":"Treatment of schizophrenia with interferon. A double-blind study","volume":"31","author":"Cabrera","year":"1990","journal-title":"Revista del Hospital Psiquiatrico de la Habana"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1192\/bjp.110.467.520","article-title":"A comparative study of oxypertine and trifluoperazine in chronic schizophrenia - a new application of the Wing Rating Scale","volume":"110","author":"Calwell","year":"1964","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003545.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/070674376801300516","article-title":"High dosage trifluoperazine in schizophrenia. Comparison of the efficacy of high and usual doses of trifluoperazine in the treatment of chronic schizophrenics","volume":"13","author":"Carscallen","year":"1968","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1176\/ajp.117.11.997","article-title":"Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextroamphetamine, imipramine, isocarboxazid and trifluoperazine added to maintanence doses of chlorpromazine","volume":"117","author":"Casey","year":"1961","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/ajp.118.6.552","article-title":"A comparison of the effectiveness of trifluoperazine and chlorpromazine in schizophrenia","volume":"118","author":"Childers","year":"1961","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1176\/ajp.119.5.462","article-title":"Procyclidine and benzotropine methanesulfonate compared in drug induced extrapyramidal reactions","volume":"1456","author":"Childers","year":"1962","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0064|cit64","first-page":"156","article-title":"Selective effectiveness of chlorpromazine and trifluoperazine in schizophrenia","volume":"23","author":"Childers","year":"1962","journal-title":"Disease of the Nervous System"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archneur.1970.00480200082009","article-title":"High doses of trifluoperazine and tardive dyskinesia","volume":"22","author":"Crane","year":"1970","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1600-0447.1974.tb08045.x","article-title":"Objective evaluation of EEG amplitude in chronic schizophrenic patients during a controlled trial of pimozide and trifluoperazine","volume":"249","author":"D'Elia","year":"1974","journal-title":"Acta Psychiatrica Scandinava Supplementum"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1099-1077(200004)15:3<179::AID-HUP156>3.0.CO;2-N","article-title":"Ritanserin as add on medication to neuroleptic therapy for patients with chronic or subchronic schizophrenia","volume":"15","author":"Boer","year":"2000","journal-title":"Human Psychopharmacology"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0033-3182(71)71533-3","article-title":"Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation","volume":"12","author":"DeWolfe","year":"1971","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00005053-196301000-00002","article-title":"The psychopharmacology of phenothiazine compounds: a comparative study of the effects of chlorpromazine, promethazine, trifluoperazine and perphenazine in normal males-I. Introduction, aims and methods","volume":"136","author":"DiMascio","year":"1965","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0447.1992.tb01446.x","article-title":"Effects of antipsychotic drugs on memory functions of schizophrenic patients","volume":"85","author":"Eitan","year":"1992","journal-title":"Acta Psychiatica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1176\/ajp.123.1.32","article-title":"Long-term prognosis and the response of schizophrenic children to drug therapy: a controlled study of trifluoperazine","volume":"123","author":"Fish","year":"1966","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/bmj.2.5088.90","article-title":"Disturbed chronic psychotic patients: pilot trial of stelazine","volume":"2","author":"Forrester","year":"1958","journal-title":"British Medical Journal"},{"issue":"12","key":"10.1002\/14651858.CD003545.pub2-BIB0073|cit73","first-page":"609","article-title":"Trifluoperazine and chlorpromazine in combination and individually","volume":"10","author":"Gardos","year":"1968","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1192\/bjp.119.552.547","article-title":"Flupenthixol and trifluoperazine: A double-blind investigation in the treatment of schizophrenics","volume":"119","author":"Gottfries","year":"1971","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1176\/ajp.117.5.453","article-title":"Trifluoperazine: a report of a clinical trial in back ward psychotic patients","volume":"117","author":"Guido","year":"1960","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-3956(70)90008-7","article-title":"Effect of phenothiazines on reaction time in schizophrenics","volume":"7","author":"Held","year":"1970","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0077|cit77","first-page":"608","article-title":"The effects of withdrawal of trifluoperazine on patients maintained on the combination of tranylcypromine and trifluoperazine: a double-blind study","volume":"85","author":"Janecek","year":"1963","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/00048677009159325","article-title":"Comparison of methylperidol and trifluoperazine in the treatment of chronic, underactive schizophrenic patients","volume":"4","author":"Jones","year":"1970","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1192\/bjp.119.552.545","article-title":"Effects of chlorpromazine and trifluoperazine on the activity of chronic schizophrenics","volume":"119","author":"Jones","year":"1971","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0080|cit80","first-page":"35","article-title":"Vitamins B1, B6 and B12 in the adjunctive treatment of schizophrenia","volume":"9","author":"Joshi","year":"1980","journal-title":"Journal of Orthomolecular Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0081|cit81","first-page":"45","article-title":"Vitamins B1, B6 and B12 in the adjunctive treatment of schizophrenia-further studies to examine the effect of reduction of chlorpromazine dosage","volume":"11","author":"Joshi","year":"1982","journal-title":"Journal of Orthomolecular Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003545.pub2-BIB0082|cit82","first-page":"745","article-title":"The place of insulin coma therapy among modern methods of treatment of paroxysmal schizophrenia patients","volume":"86","author":"Kalinin","year":"1986","journal-title":"Zhurnal Nevropatologii i Psikhiatrii imeni S.S. Korsakova"},{"issue":"6","key":"10.1002\/14651858.CD003545.pub2-BIB0083|cit83","first-page":"768","article-title":"Comparison of pimozide and trifluoperazine as once-daily therapy in chronic schizophrenic outpatients","volume":"21","author":"Kline","year":"1977","journal-title":"Current Therapeutic Research"},{"issue":"634","key":"10.1002\/14651858.CD003545.pub2-BIB0084|cit84","first-page":"302","article-title":"A double-blind comparison of thiothixene and trifluoperazine-chlorpromazine composite in the treatment of chronic schizophrenia","volume":"89","author":"Knight","year":"1979","journal-title":"New Zealand Medical Journal"},{"issue":"9","key":"10.1002\/14651858.CD003545.pub2-BIB0085|cit85","first-page":"990","article-title":"Comparison of thiopropazate and trifluoperazine on oral dyskinesia- a double-blind study","volume":"16","author":"Lal","year":"1974","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"9","key":"10.1002\/14651858.CD003545.pub2-BIB0086|cit86","first-page":"240","article-title":"A study of stelazine","volume":"6","author":"Lapolla","year":"1965","journal-title":"Western Medicine the Medical Journal of the West"},{"issue":"6","key":"10.1002\/14651858.CD003545.pub2-BIB0087|cit87","first-page":"234","article-title":"Management of behaviour symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol","volume":"48","author":"Lovett","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0088|cit88","first-page":"181","article-title":"A comparison of haloperidol and trifluoperazine. (A double-blind controlled study on chronic schizophrenic outpatients)","volume":"28","author":"Luckey","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/bmj.1.5121.549","article-title":"Trifluoperazine dihydrochloride(\"Stelazine\") in paranoid schizophrenia","volume":"1","author":"Macdonald","year":"1959","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1176\/ajp.119.1.70","article-title":"Comparison of butyrylperazine and trifluoperazine in chronic schizophrenic subjects","volume":"119","author":"Mandel","year":"1962","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0091|cit91","first-page":"542","article-title":"A comparison of tranylcypromine alone with tranylcypromine plus trifluoperazine in the treatment of chronic outpatients: a double-blind controlled study","volume":"53","author":"Mena","year":"1964","journal-title":"Journal of Cardiovascular Nursing"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005053-196507000-00010","article-title":"EEG activation of patients receiving phenothiazines and chlordiazepoxide","volume":"141","author":"Monroe","year":"1965","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0093|cit93","unstructured":"Montero E Thioridazine compared with a combination of chlorpromazine and trifluoperazine hydrochloride in schizophrenic patients 5th World Congress of Psychiatry; 1971 Nov 28- Dec 4, Ciudad de Mexico, Mexico 1971 433 72095778"},{"issue":"11","key":"10.1002\/14651858.CD003545.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/ajp.124.11.1585","article-title":"A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia","volume":"124","author":"Morton","year":"1968","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0095|cit95","first-page":"301","article-title":"A double-blind comparison of loxitane-loxapine succinate and trifluoperazine hydrocloride in chronic schizophrenic patients","volume":"36","author":"Moyano","year":"1975","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0096|cit96","first-page":"348","article-title":"Trifluoperazine in chronic withdrawn schizophrenics (a double-blind study)","volume":"23","author":"Oybir","year":"1962","journal-title":"Diseases of the Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0097|cit97","first-page":"14","article-title":"A standard (trifluoperazine) controlled clinical study with clomacran in newly admitted schizophrenic patients","volume":"13","author":"Pecknold","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"issue":"553","key":"10.1002\/14651858.CD003545.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1192\/bjp.119.553.601","article-title":"Different effects of trifluoperazine when administered daytime or night","volume":"119","author":"Polvan","year":"1971","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1176\/ajp.115.4.364","article-title":"Trifluoperazine in the treatment of psychotic patients","volume":"115","author":"Rudy","year":"1958","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003545.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0010-440X(63)80088-7","article-title":"Treatment of hospitalized schizophrenics with trifluoperazine plus tranylcypromine: a double-blind controlled study","volume":"4","author":"Schiele","year":"1963","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0101|cit101","first-page":"344","article-title":"A comparison of pargyline and tranylcypromine with and without the addition of trifluoperazine: a double-blind study","volume":"15","author":"Sharpley","year":"1964","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1192\/bjp.107.447.250","article-title":"Trifluoperazine (Stelazine) a controlled clinical trial in chronic schizophrenia","volume":"107","author":"Stanley","year":"1961","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1176\/ajp.121.6.597","article-title":"Are tranquilizers combinations more effective than a single tranquilizer?","volume":"121","author":"Talbot","year":"1964","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003545.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00048677509159857","article-title":"Tranquilizers or anti-depressants for chronic schizophrenics: A long term study","volume":"9","author":"Teja","year":"1975","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD003545.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/070674376801300607","article-title":"Neuroleptics and extrapyramidal effects: correlation between antipsychotic and extrapyramidal properties","volume":"13","author":"Tetreault","year":"1968","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1176\/ajp.115.10.935","article-title":"Preliminary observations of trifluoperazine in schizophrenia","volume":"115","author":"Tolan","year":"1959","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1176\/ajp.118.8.740","article-title":"Thioridazine (Mellaril) on regressed schizophrenic patients","volume":"119","author":"Uddyback","year":"1962","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1176\/ajp.118.3.256","article-title":"The use of stelazine and parnate in chronic, withdrawn patients","volume":"118","author":"Vogt","year":"1961","journal-title":"American journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0109|cit109","first-page":"1008","article-title":"Clinical trial of \"stelazine\"on apathetic chronic schizophrenics","volume":"106","author":"Weckowicz","year":"1960","journal-title":"Journal of Mental Science(British Journal of Psychiatry from 1963)"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"776","DOI":"10.5694\/j.1326-5377.1961.tb69141.x","article-title":"A terminal double-blind trial of trifluoperazine (\"stelazine\") in chronic schizophrenia","volume":"48","author":"Weston","year":"1961","journal-title":"The Medical Journal of Australia"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1192\/bjp.107.446.90","article-title":"A double-blind trial to investigate the effects of thorazine (largactil, chlorpromazine), compazine (stemetil, prochlorperazine) and stelazine (trifluoperazine) in paranoid schizophrenia","volume":"107","author":"Wilson","year":"1961","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0112|cit112","first-page":"161","article-title":"Clinical trial of stelazine therapy in schizophrenia refractory to alternative treatments","volume":"21","author":"Winnik","year":"1962","journal-title":"Dapim Rafuiim"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0113|cit113","first-page":"26","article-title":"The treatment of schizophrenia with long-acting oral neuroleptics: A six-month double-blind investigation of penfluridol versus trifluoperazine","volume":"13","author":"Abuzzahab","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1176\/ajp.118.4.347","article-title":"A double-blind study comparing RO 4-0403, trifluoperazine and placebo in chronically ill mental patients","volume":"118","author":"Barron","year":"1961","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD003545.pub2-BIB0115|cit115","first-page":"695","article-title":"Comparison of dosage ranges of carphenazine and trifluoperazine in elderly chronic schizophrenics","volume":"29","author":"Bora","year":"1968","journal-title":"Disease of the Nervous System"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1176\/ajp.116.9.838","article-title":"Efficacy of trifluoperazine in chronic mental ilness","volume":"116","author":"Cahan","year":"1960","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD003545.pub2-BIB0117|cit117","first-page":"524","article-title":"Psychopharmacologic characteristics of an indole compound-molindone","volume":"11","author":"Claghorn","year":"1969","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"11","key":"10.1002\/14651858.CD003545.pub2-BIB0118|cit118","first-page":"670","article-title":"Comparison of trifluoperazine and molindone in chronic schizophrenic patients","volume":"11","author":"Freeman","year":"1969","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0119|cit119","unstructured":"Gallant GP-45795 vs. trifluoperazine Early Clinical Drug Evaluation Unit Reports 2000"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0033-3182(70)71685-X","article-title":"Thiothixene and trifluoperazine in a step system","volume":"11","author":"Gardos","year":"1970","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.109.461.510","article-title":"A controlled trial on the value of prochlorperazine, trifluoperazine and intensive group treatment","volume":"109","author":"Hamilton","year":"1963","journal-title":"British Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003545.pub2-BIB0122|cit122","first-page":"298","article-title":"The clinical effects of intramuscular thiothixene and trifluoperazine in chronic schizophrenia: a comparative study","volume":"13","author":"Holden","year":"1971","journal-title":"Current Therapeutic Research"},{"issue":"505","key":"10.1002\/14651858.CD003545.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1192\/bjp.113.505.1419","article-title":"A comparison of the effects of the oxypertine and trifluoperazine in withdrawal schizophrenics","volume":"113","author":"Hunt","year":"1967","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0124|cit124","first-page":"293","article-title":"Comparative short term evaluation on penfluridol and trifluoperazine in chronic schizophrenia","volume":"32","author":"Khorana","year":"1988","journal-title":"Indian Journal of Physiology and Pharmacology"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0125|cit125","doi-asserted-by":"crossref","unstructured":"Kogeorgos J Kanellos P Michalakeas A Ioannidis J Sulpiride and risperidone vs. \"classical neuroleptics\" in schizophrenia: a follow up study 8th Congress of the European College of Neuropsychopharmacology; 1995 Sep 30- Oct 4, Venice, Italy 1995","DOI":"10.1016\/0924-977X(95)90548-R"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1192\/bjp.104.437.1195","article-title":"Stelazine (trifluoperazine) A preliminary report on a clinical trial","volume":"104","author":"Madgwick","year":"1958","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0127|cit127","doi-asserted-by":"crossref","unstructured":"Ortega-Soto HA Brunner E Apiquian R de la Torre MP Ulloa RE Typical antipsychotics: the threshold doses strategy 20th Congress of Collegium Internationale Neuro-psychopharmacologicum; 1996 june 23-27, Melbourne, Australia 1996","DOI":"10.1016\/0924-977X(96)88238-1"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0128|cit128","unstructured":"Ortega-Soto HA Brunner E Apiquian R de la Torre P Ulloa RE Mendizabal A Optimal minimum doses of trifluoperazine in acute schizophrenia 149th Annual Meeting of the American Psychiatric Association; 1996 May 4-9, New York, USA 1996"},{"issue":"9","key":"10.1002\/14651858.CD003545.pub2-BIB0129|cit129","first-page":"601","article-title":"Selective drug action related to chronic schizophrenic subtype","volume":"28","author":"Platz","year":"1967","journal-title":"Diseases of the Nervous System"},{"issue":"2","key":"10.1002\/14651858.CD003545.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00005053-196702000-00004","article-title":"The effects of carphenazine, trifluoperazine and chlorpromazine on ward behaviour, physiological functioning and psychological test scores in chronic schizophrenic patients","volume":"144","author":"Spiegel","year":"1967","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0131|cit131","first-page":"208","article-title":"The position of trifluoperazine in the group of neuroleptics (a controlled clinical comparative study)","volume":"17","author":"Svetska","year":"1975","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0132|cit132","first-page":"24","article-title":"Comparison of influence of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit schizophrenic symptoms in patients first hospitalized because of paranoid schizophrenia","volume":"23","author":"Terminska","year":"1989","journal-title":"Psychiatria Polska"},{"issue":"10","key":"10.1002\/14651858.CD003545.pub2-BIB0133|cit133","first-page":"787","article-title":"A double-blind cross-over comparison of oxypertine with trifluoperazine in chronic schizophrenia","volume":"11","author":"Toru","year":"1969","journal-title":"Rinsyo Igaku"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0134|cit134","first-page":"448","article-title":"Clinical experience with trifluoperazine","volume":"8","author":"Vinar","year":"1966","journal-title":"Activitas Nervosa Superior"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0135|cit135","first-page":"174","article-title":"Thiothixene in schizophrenic psychoses","volume":"13","author":"Vinar","year":"1971","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00421786","article-title":"Trifluoperazine: a comparison between regular and high doses","volume":"36","author":"Wijsenbeek","year":"1974","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD003545.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/ajp.154.4.1","article-title":"Practice guideline for the treatment of patients with schizophrenia","volume":"154","author":"American Psychiatric Association","year":"1997","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0139|cit139","volume-title":"Handbook of Psychiatric Drug Therapy","author":"Arana","year":"2000"},{"issue":"5","key":"10.1002\/14651858.CD003545.pub2-BIB0140|cit140","first-page":"423","article-title":"Clinical pharmacology of the phenothiazines","volume":"8","author":"Ban","year":"1966","journal-title":"Applied Therapeutics"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0141|cit141","volume-title":"Psychotropic Drug Directory","author":"Bazire","year":"2000"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0143|cit143","unstructured":"Clarke M Oxman D Cochrane Collaboration Handbook Cochrane Database of Systematic Reviews 2001"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0144|cit144","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001359.pub2","article-title":"Olanzapine for schizophrenia","author":"Duggan","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(97)02419-7","article-title":"Language bias in randomised controlled trials published in English and German","volume":"350","author":"Egger","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD003545.pub2-BIB0146|cit146","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001943.pub2","article-title":"Loxapine for schizophrenia","author":"Fenton","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis","volume":"321","author":"Geddes","year":"2000","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0148|cit148","first-page":"217","volume-title":"Early clinical drug evaluation (ECDEU) assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO;2-I","article-title":"The Nurses Observation Scale for Impatient Evaluation (NOSIE): a new scale for measuring improvment in chronic schizophrenia","volume":"21","author":"Honingfeld","year":"1965","journal-title":"Journal of Clinical Psychology"},{"issue":"Issue 4","key":"10.1002\/14651858.CD003545.pub2-BIB0150|cit150","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000440","article-title":"Risperidone versus typical antipsychotic medication for schizophrenia","author":"Hunter","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003545.pub2-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003082.pub2","article-title":"Haloperidol versus placebo for schizophrenia","author":"Joy","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0152|cit152","volume-title":"Pocket handbook of clinical psychiatry","author":"Kaplan","year":"1998"},{"issue":"3","key":"10.1002\/14651858.CD003545.pub2-BIB0153|cit153","first-page":"181","article-title":"A comparison of haloperidol and trifluoperazine.A double-blind, controlled study on chronic schizophrenic outpatients","volume":"28","author":"Luckey","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0154|cit154","first-page":"16","article-title":"Cost-efectiveness of clozapine treatment","volume":"14","author":"Meltzer","year":"1996","journal-title":"Journal of Clinical Psychiatry. Monograph Series"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1176\/ajp.146.6.726","article-title":"Changing patterns of neuroleptic dosage over a decade","volume":"146","author":"Reardon","year":"1989","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003545.pub2-BIB0158|cit158","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001162","article-title":"Sulpiride for schizophrenia","author":"Soares","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003545.pub2-BIB0159|cit159","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000967.pub2","article-title":"Quetiapine for schizophrenia","author":"Srisurapanont","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003545.pub2-BIB0160|cit160","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000284.pub2","article-title":"Chlorpromazine versus placebo for schizophrenia","author":"Thornley","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003545.pub2-BIB0161|cit161","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000059","article-title":"Clozapine versus typical neuroleptic medication for schizophrenia","author":"Wahlbeck","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1192\/bjp.107.450.862","article-title":"A simple and reliable subclassification of chronic schizophrenia","volume":"107","author":"Wing","year":"1961","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD003545.pub2-BIB0163|cit163","first-page":"9","article-title":"Review of the global schizophrenia market","volume":"39","author":"Wood","year":"1998","journal-title":"PharmaForum"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003545.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T20:15:18Z","timestamp":1682626518000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003545.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,1,26]]},"references-count":163,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003545.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,26]]}}}